TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Gross profit as a percentage of revenue
3Y CAGR
-5.1%/yr
Annual compound
Percentile
P33
Within normal range
vs 3Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | 85.57% | -14.4% |
| 2024 | 100.00% | 0.0% |
| 2023 | 100.00% | 0.0% |
| 2022 | 100.00% | 0.0% |
| 2021 | 100.00% | +105.6% |
| 2020 | -1796.50% | - |
| 2019 | 0.00% | - |